0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover203.54%IV-57.89%PremiumDec 20, 2024Expiry Date2.75Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9797Delta0.0215Gamma1.71Leverage Ratio-0.0029Theta0.0010Rho1.68Eff Leverage0.0005Vega
Westport Fuel Stock Discussion
NEWS
Westport Fuel Systems Inc. welcomes the EU's revised CO2 emissions reduction targets for heavy-duty vehicles, with a focus on achieving climate neutrality. Their H2 HPDI fuel system solution is aligned with ZEV regulations, offering a cost-effective and high-performance option for decarbonization in the transportation industry.
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
No comment yet